Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Herbalife exec

This article was originally published in The Tan Sheet

Executive Summary

Gregory Probert named chief operating officer, with "overall responsibility" for the supplement marketer's business operations in 58 markets around the world, Herbalife says. He joins Herbalife from DMX Music, where he was president and chief executive officer. He also formerly served as exec VP-COO for Disney's Buena Vista Home Entertainment business. Probert replaces Brian Kane, who is relocating to the UK to take over as president of Herbalife Europe. Probert's appointment follows that of former Nokia Mobile Phones VP Michael Wisk as Herbalife's chief marketing officer (1"The Tan Sheet" July 28, 2003, In Brief)...

You may also be interested in...

Herbalife appointment

Newly appointed General Counsel Brett Chapman will address legal matters in all 58 countries where company operates, L.A.-based firm announces. Chapman most recently served as deputy general counsel for The Walt Disney Company. Announcement follows the appointment of another former Disney exec, Gregory Probert, who was named Herbalife's COO in August (1"The Tan Sheet" Aug. 18, 2003, In Brief)...

Herbalife appointment

Michael Wisk named chief marketing officer for direct seller, Los Angeles-based firm announced July 21. Newly created position places Wisk in charge of worldwide marketing, including distributors, in 58 countries. Wisk, who most recently was VP-marketing for Nokia Mobile Phones for North and South America, will report to CEO Michael Johnson. Announcement follows recent appointment of former Pharmavite co-founder and CEO Henry Burdick as Herbalife vice chairman (1"The Tan Sheet" June 16, 2003, p.14)...

Neuroscience Challenges Oncology For Top Spot In CDER’s 2019 Novel Approvals

Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts